CHEMED CORPORATION

(CHE)
  Report
Delayed Nyse  -  04:00 2022-07-01 pm EDT
480.92 USD   +2.46%
06/29Chemed Obtains $550 Million Senior Secured Credit Facility
MT
06/29CHEMED : Announces a Five-Year $550 Million Amended and Restated Senior Secured Credit Facility - Form 8-K
PU
06/29CHEMED CORP : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)
AQ
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
06/27/2022 06/28/2022 06/29/2022 06/30/2022 07/01/2022 Date
470.97(c) 468.5(c) 477.57(c) 469.39(c) 480.92(c) Last
68 382 45 479 36 268 93 193 55 447 Volume
+0.90% -0.52% +1.94% -1.71% +2.46% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 2 172 M - -
Net income 2022 269 M - -
Net Debt 2022 - - -
P/E ratio 2022 27,1x
Yield 2022 0,28%
Sales 2023 2 273 M - -
Net income 2023 294 M - -
Net Debt 2023 - - -
P/E ratio 2023 24,6x
Yield 2023 0,28%
Capitalization 7 167 M 7 167 M -
Capi. / Sales 2022 3,30x
Capi. / Sales 2023 3,15x
Nbr of Employees 14 137
Free-Float 39,8%
More Financials
Company
Chemed Corporation is focused on purchasing, operating, and divests subsidiaries in diverse business activities. The Company’s segments include VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. The Company's... 
More about the company
Ratings of Chemed Corporation
Trading Rating :  -
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about CHEMED CORPORATION
06/29Chemed Obtains $550 Million Senior Secured Credit Facility
MT
06/29CHEMED : Announces a Five-Year $550 Million Amended and Restated Senior Secured Credit Fac..
PU
06/29CHEMED CORP : Entry into a Material Definitive Agreement, Creation of a Direct Financial O..
AQ
06/29Chemed Corporation Announces a Five-Year $550 Million Amended and Restated Senior Secur..
BU
06/29Chemed Corporation Announces A Five-Year $550 Million Amended and Restated Senior Secur..
CI
06/13INSIDER SELL : Chemed
MT
06/09TRANSCRIPT : Chemed Corporation Presents at 2022 Jefferies Global Healthcare Conference, J..
CI
06/02Chemed Corporation to Present at the Jefferies 2022 Healthcare Conference
BU
05/25CHEMED CORPORATION : Ex-dividend day for
FA
05/18TRANSCRIPT : Chemed Corporation Presents at RBC Capital Markets Global Healthcare Conferen..
CI
05/17CHEMED CORP : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
05/16INSIDER SELL : Chemed
MT
05/16Chemed Maintains Quarterly Cash Dividend at $0.36 a Share, Payable June 15 to Sharehold..
MT
05/16Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Divid..
BU
05/16Chemed Corporation Declares Quarterly Cash Dividend, Payable on June 15, 2022
CI
More news
News in other languages on CHEMED CORPORATION
06/13VENTE D'INITIÉS : Chemed
05/16VENTE D'INITIÉS : Chemed
05/16Chemed Corporation déclare un dividende trimestriel en espèces, payable le 15 juin 2022
05/11VENTE D'INITIÉS : Chemed
05/11VENTE D'INITIÉS : Chemed
More news
Analyst Recommendations on CHEMED CORPORATION
More recommendations
Chart CHEMED CORPORATION
Duration : Period :
Chemed Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CHEMED CORPORATION
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 480,92 $
Average target price 582,33 $
Spread / Average Target 21,1%
EPS Revisions
Managers and Directors
Kevin J. McNamara Vice Chairman, Secretary & General Counsel
David Patrick Williams Chief Financial Officer & Executive Vice President
George J. Walsh Director
Lisa A. Reinhard Chief Administrative Officer & Vice President
Joel F. Gemunder Independent Director
Sector and Competitors